Adaptam Therapeutics
PrivateLast Round
Pre Seed
Oct 27, 2025
Total Funding Raised
$3.5M
Company Overview
Adaptam Therapeutics operates in Healthcare & Life Sciences and is based in Spain. Its latest recorded funding round was a Pre Seed round in October 2025.
Adaptam Therapeutics is a biotechnology company that develops first-in-class antibody therapies, including antibody-drug conjugates (ADCs) and bispecific antibodies, for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptam Therapeutics Comparables
Compare Adaptam Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LTZ Therapeutics | 82% | |
| Resolute Science | 79% | |
| Palleon Pharmaceuticals | 77% |
For institutional investors. Book with your work email.
Adaptam Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Adaptam Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Criteria Capital Risc | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 338% MoM, reaching 1.1K.
- Oct 27, 2025
$4M raised with Criteria Capital Risc and criteriabioventures leading.
For institutional investors. Book with your work email.
Adaptam Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Adaptam Therapeutics's valuation, stock price, and market status.
Is Adaptam Therapeutics a public or private company?
Adaptam Therapeutics is a private company.
What is the current stock price of Adaptam Therapeutics?
Adaptam Therapeutics is a private company, so its shares have no public market price. Caplight tracks Adaptam Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adaptam Therapeutics worth (valuation)?
Valuation information for Adaptam Therapeutics is not publicly available.
Can I buy Adaptam Therapeutics stock?
Adaptam Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adaptam Therapeutics's last funding round?
Adaptam Therapeutics's most recent funding round was Pre Seed on October 27, 2025.
Who are the main investors in Adaptam Therapeutics?
Key investors in Adaptam Therapeutics include Criteria Capital Risc.
Will Adaptam Therapeutics IPO soon?
No public IPO plans have been announced for Adaptam Therapeutics.
How can I track Adaptam Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Adaptam Therapeutics's shares on secondary markets.